-
Tomorrow's worldInnovation in treatment new
Rheumatic heart disease valves show B-cell activity, and rituximab is tested in children
Rheumatic mitral valves showed raised B-cell pathways, and rituximab was well tolerated in children with rheumatic heart disease in Senegal.
Preprint · not peer-reviewed